DK0437554T3 - Farmaceutisk præparat og fremgangsmåde til inhibering af virus - Google Patents

Farmaceutisk præparat og fremgangsmåde til inhibering af virus

Info

Publication number
DK0437554T3
DK0437554T3 DK90908811.4T DK90908811T DK0437554T3 DK 0437554 T3 DK0437554 T3 DK 0437554T3 DK 90908811 T DK90908811 T DK 90908811T DK 0437554 T3 DK0437554 T3 DK 0437554T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
inhibiting viruses
inhibiting
butyl
viruses
Prior art date
Application number
DK90908811.4T
Other languages
English (en)
Inventor
Martin Stanley Hirsch
Victoria Anne Johnson
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK0437554T3 publication Critical patent/DK0437554T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90908811.4T 1989-06-02 1990-05-09 Farmaceutisk præparat og fremgangsmåde til inhibering af virus DK0437554T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/360,439 US5011829A (en) 1989-06-02 1989-06-02 Pharmaceutical composition and method of inhibiting virus

Publications (1)

Publication Number Publication Date
DK0437554T3 true DK0437554T3 (da) 1992-12-07

Family

ID=23417957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908811.4T DK0437554T3 (da) 1989-06-02 1990-05-09 Farmaceutisk præparat og fremgangsmåde til inhibering af virus

Country Status (10)

Country Link
US (1) US5011829A (da)
EP (2) EP0437554B1 (da)
JP (1) JPH04500220A (da)
AT (1) ATE81979T1 (da)
CA (1) CA2030803A1 (da)
DE (1) DE69000434T2 (da)
DK (1) DK0437554T3 (da)
IE (1) IE64352B1 (da)
PT (1) PT94247B (da)
WO (1) WO1990014830A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
WO1992004055A1 (en) * 1990-09-06 1992-03-19 The Australian National University Immunosuppressant composition
AU654152B2 (en) * 1990-09-06 1994-10-27 Australian National University, The Immunosuppressant composition
DE69206876T3 (de) * 1991-05-16 2004-08-12 Glaxo Group Ltd., Greenford Nukleosidanalogen enthaltende Antiviren-Zubereitungen
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5342951A (en) * 1992-04-01 1994-08-30 G.D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
FI950696A7 (fi) * 1992-08-19 1995-02-16 Schering Corp Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä
US5798366A (en) * 1993-05-13 1998-08-25 Monsanto Company Method for treatment of CNS-involved lysosomal storage diseases
US6291657B1 (en) * 1993-05-13 2001-09-18 Monsanto Company Deoxygalactonojirimycin derivatives
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US20030100532A1 (en) * 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
DK1030839T3 (da) 1997-11-10 2004-05-03 Searle & Co Anvendelse af alkylerede iminosukkere til behandling af multidrugresistens
US6809083B1 (en) 1998-02-12 2004-10-26 Richard A. Mueller Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
ATE402701T1 (de) 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
US6569616B1 (en) * 1999-07-29 2003-05-27 Wisconsin Alumni Research Foundation Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate
EP1261339A1 (en) * 2000-02-14 2002-12-04 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
US7884115B2 (en) * 2004-09-28 2011-02-08 Allergan, Inc. Methods and compositions for the treatment of pain and other neurological conditions
AU2006247065B8 (en) 2005-05-17 2012-07-12 Amicus Therapeutics, Inc. A method for the treatment of Pompe disease using 1-deoxynojirimycin derivatives
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
KR20230066482A (ko) 2012-03-07 2023-05-15 아미쿠스 세라퓨틱스, 인코포레이티드 폼페병의 치료를 위한 고농도 알파-글루코시다제 조성물
CN114540327B (zh) 2014-09-30 2026-03-24 阿米库斯治疗学公司 具有增强的碳水化合物的高强度酸性α-葡糖苷酶
KR102747683B1 (ko) 2015-12-30 2024-12-31 아미쿠스 세라퓨틱스, 인코포레이티드 폼페병 치료용의 강화된 산 알파-글루코시다제
SG11201808455VA (en) 2016-03-30 2018-10-30 Amicus Therapeutics Inc Formulations comprising recombinant acid alpha-glucosidase
JP7046003B2 (ja) 2016-03-30 2022-04-01 アミカス セラピューティックス インコーポレイテッド 高ｍ６ｐ組換えタンパク質の選択方法
ES2950808T3 (es) 2017-05-15 2023-10-13 Amicus Therapeutics Inc Alfa-glucosidasa ácida humana recombinante
CN109456254B (zh) * 2018-12-06 2020-06-30 江西农业大学 1-脱氧野尻霉素-羟基查尔酮杂合体衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US4857511A (en) * 1985-09-17 1989-08-15 Burroughs Wellcome Co. Treatment of human viral infections
JPS63175354A (ja) * 1987-01-16 1988-07-19 Shin Kobe Electric Mach Co Ltd 電池用渦巻電極体の製造装置
EP0282618A1 (en) * 1987-03-18 1988-09-21 Vereniging Het Nederlands Kanker Instituut 1-Deoxynojirimycin as an anti-HIV therapeutic
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus

Also Published As

Publication number Publication date
US5011829A (en) 1991-04-30
IE901973L (en) 1990-12-02
WO1990014830A1 (en) 1990-12-13
EP0401194A1 (en) 1990-12-05
DE69000434D1 (de) 1992-12-10
ATE81979T1 (de) 1992-11-15
PT94247B (pt) 1997-05-28
CA2030803A1 (en) 1990-12-03
JPH04500220A (ja) 1992-01-16
IE64352B1 (en) 1995-07-26
EP0437554B1 (en) 1992-11-04
DE69000434T2 (de) 1993-05-27
PT94247A (pt) 1991-02-08
EP0437554A1 (en) 1991-07-24

Similar Documents

Publication Publication Date Title
DE69000434D1 (de) Pharmazeutische zusammensetzung und verfahren zur virushemmung.
KR0179637B1 (en) Diaromatic substituted compounds as anti-hiv-1 agents
PT87703A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um derivado de 1,4-di-hidropiridina e um intensificador do fluxo transdermico
FI923443A7 (fi) Yhdisteitä ja menetelmiä HIV:n ja sen kaltaisten virusten inhiboimiseksi
DE69425135D1 (en) Substituierte cyclische carbonylderivate und analoga verwendbar als retrovirale proteasehemmer
DK1102588T3 (da) Farmaceutiske sammensætninger til forebyggelse og behandling af sygdomme i centralnervesystemet indeholdende en nikotinanalog og en acetylcholinesteraseinhibitor
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
OA09378A (fr) "Nouveaux dérivés de la pipéridine, de la tétrahydropyridine et de la pyrrolidine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
DK0693285T3 (da) Farmaceutiske præparater, der indeholder et bisphosphonat og et antiresorberende middel til inhibering af knogletab
FI943316L (fi) Farmaseuttiset koostumukset, joissa on nifedipiiniä ja menetelmä sen valmistamiseksi
FI941836A7 (fi) 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
NZ237340A (en) N-benzoyl-4-indanyl-(and tetrahydronaphthalenyl-)aminomethyl piperidine derivatives; preparatory processes and pharmaceutical compositions
DK249688A (da) Laegemiddelkombination til forebyggelse og behandling af malaria
AU1463992A (en) Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus
DK308488A (da) Farmaceutisk praeparat til behandling af en retrovirusinfektion
DK545889D0 (da) Anti-human-immundefektvirus-praeparat
DK708188D0 (da) 5- og 6-leddede heterocycliske forbindelser og farmaceutisk acceptable saltderivater heraf til anvendelse ved behandling af aids
PT101238A (pt) Composicoes a base de 1-(2'-desoxi-2'-fluoro-beta-d-arabinofuranosil)-5-iodo-uracilo para tratamento de infeccao e doenca causada pelo virus da hepatite b, sua preparacao e uso
PT89266A (pt) Metodo para a inibicao de virus da imunodeficiencia humana utilizando um derivado n-n-butilo de desoxinojirimicina
DK420687D0 (da) Injicerbart farmaceutisk praeparat til inducering og opretholdelse af anaestesi, samt en fremgangsmaade til anvendelse heraf
DK74789D0 (da) Optisk aktive rhodiumkomplekser af 3,4-bis(diarylphosphino)pyrrolidiner, deres fremstilling og anvendelse
DK0427526T3 (da) Pyridinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
ATE141052T1 (de) Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro- 2,6-dimethyl-4-(3-nitrophenyl)-3,5-
NO943826D0 (no) Heteroarylpiperidiner, fremgangsmåte for fremstilling og farmasöytiske blandinger hvor de er tilstede
FI922839A7 (fi) Menetelmä trombosytopenian hoitamiseksi ja siinä käytettävät farmaseut tiset koostumukset